Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region

被引:92
|
作者
Ofek, Gilad [1 ]
McKee, Krisha [1 ]
Yang, Yongping [1 ]
Yang, Zhi-Yong [1 ]
Skinner, Jeff [2 ]
Guenaga, F. Javier [1 ]
Wyatt, Richard [1 ]
Zwick, Michael B. [3 ]
Nabel, Gary J. [1 ]
Mascola, John R. [1 ]
Kwong, Peter D. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA
[3] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSITION-STATE ANALOG; MONOCLONAL-ANTIBODIES; VENOM PHOSPHOLIPASE-A2; ENVELOPE GLYCOPROTEIN; ECTODOMAIN REGION; CRYSTAL-STRUCTURE; GP41; ECTODOMAIN; ANTI-GP41; 2F5; MEMBRANE;
D O I
10.1128/JVI.02257-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal external region (MPER) of the HIV-1 gp41 transmembrane glycoprotein is the target of the broadly neutralizing antibody 2F5. Prior studies have suggested a two-component mechanism for 2F5-mediated neutralization involving both structure-specific recognition of a gp41 protein epitope and nonspecific interaction with the viral lipid membrane. Here, we mutationally alter a hydrophobic patch on the third complementarity-determining region of the heavy chain (CDR H3) of the 2F5 antibody and assess the abilities of altered 2F5 variants to bind gp41 and to neutralize diverse strains of HIV-1. CDR H3 alterations had little effect on the affinity of 2F5 variants for a peptide corresponding to its gp41 epitope. In contrast, strong effects and a high degree of correlation (P < 0.0001) were found between virus neutralization and CDR H3 hydrophobicity, as defined by predicted free energies of transfer from water to a lipid bilayer interface or to octanol. The effect of CDR H3 hydrophobicity on neutralization was independent of isolate sensitivity to 2F5, and CDR H3 variants with tryptophan substitutions were able to neutralize HIV-1 similar to 10-fold more potently than unmodified 2F5. A threshold was observed for increased hydrophobicity of the 2F5 CDR H3 loop beyond which effects on 2F5-mediated neutralization leveled off. Together, the results provide a more complete understanding of the 2F5 mechanism of HIV-1 neutralization and indicate ways to enhance the potency of MPER-directed antibodies.
引用
收藏
页码:2955 / 2962
页数:8
相关论文
共 50 条
  • [21] Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids
    Apellaniz, Beatriz
    Garcia-Saez, Ana J.
    Huarte, Nerea
    Kunert, Renate
    Vorauer-Uhl, Karola
    Katinger, Hermann
    Schwille, Petra
    Nieva, Jose L.
    FEBS LETTERS, 2010, 584 (08) : 1591 - 1596
  • [22] Recognition of Membrane-Bound Fusion-Peptide/MPER Complexes by the HIV-1 Neutralizing 2F5 Antibody: Implications for Anti-2F5 Immunogenicity
    Huarte, Nerea
    Araujo, Aitziber
    Arranz, Rocio
    Lorizate, Maier
    Quendler, Heribert
    Kunert, Renate
    Valpuesta, Jose M.
    Nieva, Jose L.
    PLOS ONE, 2012, 7 (12):
  • [23] P19-12. Multimers of llama heavy chain variable domains that bind to the 2F5/4E10 epitope neutralize HIV-1
    Y Liu
    ME Khatttabi
    A Forsman
    MM Asaa-Chapman
    RA Weiss
    H Langedijk
    A Hinz
    W Weissenhorn
    H de Haard
    T Verrips
    Retrovirology, 6
  • [24] Study 1: Optimizing DNA Vaccines that Target the 2F5 Epitope of the Membrane Proximal External Region of HIV-1 gp41
    Gulzar, N.
    Klaric, K.
    Parfyonov, M.
    Montero, M.
    Wang, S.
    Huarte, N.
    Appellaniz, B.
    Nieva, J.
    Lu, S.
    Scott, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A158 - A158
  • [25] Structural Constraints Imposed by the Conserved Fusion Peptide on the HIV-1 gp41 Epitope Recognized by the Broadly Neutralizing Antibody 2F5
    de la Arada, Igor
    Julien, Jean-Philippe
    de la Torre, Beatriz G.
    Huarte, Nerea
    Andreu, David
    Pai, Emil F.
    Arrondo, Jose L. R.
    Nieva, Jose L.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2009, 113 (41): : 13626 - 13637
  • [26] COMPARISON OF THE MOUSE ANTIBODY-RESPONSE TO DIFFERENT ANTIGENIC FORMULATIONS INCORPORATING A SYNTHETIC PEPTIDE REPRESENTING THE HEAVY-CHAIN 2ND COMPLEMENTARITY-DETERMINING REGION OF A MOUSE MONOCLONAL ANTI-CD4 ANTIBODY
    KANDA, P
    FRITZ, DA
    DUNHAM, RG
    SHULER, KR
    LOHMAN, KL
    KENNEDY, RC
    BUCK, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) : 1385 - 1385
  • [27] Structure-guided Alterations of the gp41-directed HIV-1 Broadly Neutralizing Antibody 2F5 Reveal New Properties Regarding its Neutralizing Function
    Guenaga, Javier
    Wyatt, Richard T.
    PLOS PATHOGENS, 2012, 8 (07): : 28
  • [28] HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10:: in vitro experiments versus clinical studies
    Nakowitsch, S
    Quendler, H
    Fekete, H
    Kunert, R
    Katinger, H
    Stiegler, G
    AIDS, 2005, 19 (17) : 1957 - 1966
  • [29] β-Actin-binding Complementarity-determining Region 2 of Variable Heavy Chain from Monoclonal Antibody C7 Induces Apoptosis in Several Human Tumor Cells and Is Protective against Metastatic Melanoma
    Arruda, Denise C.
    Santos, Luana C. P.
    Melo, Filipe M.
    Pereira, Felipe V.
    Figueiredo, Carlos R.
    Matsuo, Alisson L.
    Mortara, Renato A.
    Juliano, Maria A.
    Rodrigues, Elaine G.
    Dobroff, Andrey S.
    Polonelli, Luciano
    Travassos, Luiz R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (18) : 14912 - 14922
  • [30] Heterologous Epitope-Scaffold Prime:Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
    Guenaga, Javier
    Dosenovic, Pia
    Ofek, Gilad
    Baker, David
    Schief, William R.
    Kwong, Peter D.
    Hedestam, Gunilla B. Karlsson
    Wyatt, Richard T.
    PLOS ONE, 2011, 6 (01):